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Abstract
Background: Medium density DNA microchips that carry a collection of probes for a broad
spectrum of pathogens, have the potential to be powerful tools for simultaneous species
identification, detection of virulence factors and antimicrobial resistance determinants. However,
their widespread use in microbiological diagnostics is limited by the problem of low pathogen
numbers in clinical specimens revealing relatively low amounts of pathogen DNA.
Results: To increase the detection power of a fluorescence-based prototype-microarray designed
to identify pathogenic microorganisms involved in sepsis, we propose a large scale multiplex PCR
(LSplex PCR) for amplification of several dozens of gene-segments of 9 pathogenic species. This
protocol employs a large set of primer pairs, potentially able to amplify 800 different gene segments
that correspond to the capture probes spotted on the microarray. The LSplex protocol is shown
to selectively amplify only the gene segments corresponding to the specific pathogen present in the
analyte. Application of LSplex increases the microarray detection of target templates by a factor of
100 to 1000.
Conclusion: Our data provide a proof of principle for the improvement of detection of pathogen
DNA by microarray hybridization by using LSplex PCR.
Background
Clinical microbiological diagnostics, environmental sur-
vey, food quality control and biodefence strategies have a
common keystone: accurate and rapid identification of
pathogenic microorganisms. Several molecular biology-
based methods have been recently developed for micro-
bial diagnostics and offer noticeable advantages over con-
ventional techniques in microbiology. Among the
molecular biology-based methods, DNA microarray tech-
nology presents the potential of direct and rapid identifi-
cation of multiple DNA sequences [1-7]. A microarray
displaying DNA probes corresponding to a collection of
genes of a broad spectrum of pathogens is a powerful tool
for simultaneous species identification, detection of viru-
lence factors and antimicrobial resistance determinants
[2]. Major drawbacks in using DNA microarrays as a
standard technique for pathogen detection are linked to
the low representation of pathogen DNA in the analytes,
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but also to the relatively low sensitivity of fluorescence-
based microarrays. The amount of specific pathogen DNA
present in clinical, environmental, and food samples is
sometimes as low as few femtograms [8-14], while the
detection limit for genomic DNA in fluorescence-based
microarrays, without any pre-amplification, is in the
range of micrograms to nanograms [1,3,4,7,15].
A solution to overcome this intrinsic weakness of fluores-
cence-based microarrays is to specifically amplify the
pathogen DNA fraction in the sample in order to increase
the sensitivity level of detection. The question of random
or selective pathogen DNA amplification prior to DNA
microarray detection has been already addressed [16] and
applications of multiplex PCR using a small number of
primer pairs corresponding to the capture probes on low
density microarrays have been published [16,5,6,16-18].
We present here a further development of this approach,
by proposing a large scale multiplex PCR adapted to the
format of a prototype medium density microarray devel-
oped in our laboratory, employing up to 800 specific
primer pairs. The limiting conditions for the LSplex PCR
protocol are empirically determined and the resulting
amplification biases are evaluated.
Methods
Strains of microorganisms used for the preparation of DNA 
templates
Template DNA was prepared from the following bacterial
and fungal reference strains, obtained from the American
Type Culture Collection (ATCC, Manassas, Va.), the Deut-
sche Sammlung von Mikroorganismen und Zellkulturen
(DSMZ, Braunschweig, Germany) or the Collection de
l'Institut Pasteur, (CIP, Paris, France): Staphylococcus
aureus (ATCC 29213 and CIP 65.6), Staphylococcus epider-
midis (ATCC 12228), Escherichia coli (ATCC 25922 and
CIP 105893), Pseudomonas aeruginosa (ATCC 27853 and
CIP 105765), Klebsiella pneumoniae (DSM 681), Proteus
mirabilis (DSM 788), Enterococcus faecalis (ATCC 29212),
Streptococcus pneumoniae (CIP 106577), Streptococcus mitis
(CIP 104997), Candida albicans (ATCC 10231). A clinical
isolate of S. aureus (T100) was also used in some experi-
ments. Microorganisms were grown over night at 37°C
with constant shaking at 220 rpm in 5 ml Luria-Bertani
(LB) broth or tryptic soy broth (TSB, 30 g/l, Merck) con-
taining 3 g/l yeast extract. Enterococci and Streptococci
were grown in 10 ml TSB plus yeast without agitation
under 5% CO2. Overnight cultures were harvested at
2,560 g for 10 min. After discarding the supernatant the
pellet was washed in 1 ml TE (10 mM Tris-HCl, pH 7.5
and 1 mM EDTA) and recovered by centrifugation at
17,900 g for 10 min. Cell pellets were used for DNA prep-
aration. Clinical samples were obtained from the routine
microbiological laboratory were they were characterized
by subculture and standard biochemical identification
(VITEK2).
DNA template preparation
Total bacterial DNAs were extracted and purified by using
the Bacterial Genomic DNA Purification Kit (EdgeBioSys-
tems, Gaithersburg, MD, USA) following the instructions
of the supplier. For Gram-positive bacteria the cell pellets
were resuspended in 200 μL TES buffer (20 mM Tris-HCl,
pH 7.5, 10 mM EDTA pH 8.0 and 50 mM NaCl) contain-
ing lysozyme (Sigma, Taufkirchen, Germany) in a final
concentration of 0.8 g/L prior to extraction. In additon,
lysostaphin (Sigma) was added to a final concentration of
0.2 g/L, to promote Staphylococcal lysis, or mutanolysin
(0.5 U/μL; Sigma) was added to lyse Streptococci and
Enterococci and incubated one hour at 37°C. Candida
albicans DNA extraction was achieved by beating the cell
pellet with glass beads (425–600 microns, Sigma) using a
Tissue Lyser (Qiagen, Hilden, Germany) at maximum
speed for 5 minutes and the DNeasy Tissue Kit (Qiagen)
with an overnight Proteinase K (10 mg/L) treatment. DNA
from cotton swabs was prepared by DNeasy Tissue Kit
(Qiagen) followed by manufacturer's protocol for the
purification of genomic DNA from Gram+ bacteria.
Construction of the prototype microarray
A total of 930 gene segments of Staphylococcus spp., Strep-
tococcus spp., Enterococcus spp., Proteus spp., Klebsiella spp.,
Stenotrophomonas sp., Enterobacter sp., Acinetobacter spp., E.
coli, P. aeruginosa, and Candida albicans and genes encod-
ing resistance against antimicrobials were selected from
the literature and databases. Next they were compared by
BLAST analysis to all other sequences available in the
NCBI database in order to avoid regions homologous
with genes of other bacterial species and Homo sapiens.
Primers for the selected sequences were designed with the
help of Primer3 search [19] in order to produce amplicons
of 200 to 800 bp length (primer sequences and their char-
acteristics are shown in Additional file 1).
Negative controls comprising genes of Homo sapiens, Dic-
tyostelium discoideum, Mus musculus and Hordeum vulgaris
and positive controls (16S rRNA genes of several bacterial
species) were also included. PCR products were cloned
following the detailed protocol described elsewhere [2].
All cloned gene segments were amplified from the plas-
mids and diluted in 25% DMSO at a concentration of 200
mg/L. For printing the microarrays a BioRobotics Microg-
rid 610 spotter (Genomic Solutions, Huntingdon, UK)
and Ultra-GAPS™ coated glass slides (Corning Incorpo-
rated, Corning, USA) were used and conditions for print-
ing were as described [20]. The complete array of 930 gene
amplicons was spotted in 2 replicates per slide, each rep-
licate containing 2 spots of the same probe, therefore tota-
ling 4 replicates of each probe. Each lot of microarrays wasBMC Microbiology 2009, 9:1 http://www.biomedcentral.com/1471-2180/9/1
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quality controlled by hybridization with 2 μg genomic
DNA of reference strains of pathogens present on the
array.
Multiplex PCR
For testing the Large-scale Multiplex PCR (LSplex)
approach, 800 primer-pairs were selected out of the 930
available primer-pairs. (Additional file 1).
LSplex was carried out with different amounts of pure cul-
ture bacterial DNA templates. A primer mix was used with
a final concentration of in general 0.02 μM of each primer.
Reactions in a total volume of 50 μL were performed with
2 U either of Taq DNA polymerase (Fermentas, St. Leon-
Rot, Germany) (standard LSplex) or Vent exo-  DNA
polymerase (New England Biolabs, Frankfurt am Main,
Germany) (optimized LSplex). Standard LSplex using Taq
DNA polymerase amplification reactions contained 1×
KCl PCR buffer (Fermentas), 2 mM MgCl2, and 0.2 mM of
dATP, dCTP, gGTP, and dTTP (Sigma). Optimized LSplex
using Vent exo- DNA polymerase amplification reactions
contained 1× ThermoPolBuffer (New England Biolabs), 4
mM MgCl2, and 0.2 mM of dATP, dCTP, dGTP, and dTTP
(Sigma). The cycling was performed in Trio T3 Thermocy-
cler (Biometra, Goettingen, Germany) using protocol
comprising an initial denaturing step at 94°C for 3 min-
utes, followed by 35 cycles of 94°C for 30 s, 55°C for 45
s and 72°C for 1 min. LSplex products were spin purified
with the QIAquick PCR Purification Kit (Qiagen) and
eluted with nuclease-free water (pH 8).
Labelling of multiplex amplified products for microarray 
hybridization experiments
LSplex amplified products were labelled with fluoro-
phores after or during amplification.
1. Labelling after amplification
Purified LSplex products in a volume of 20 μL were
labelled with 3 μL of either Cy5-dCTP or Cy3-dCTP
(Amersham Pharmacia Biotech Europe, Freiburg, Ger-
many) by random priming using Klenow Polymerase (50
units) (BioPrime DNA labelling Kit, Invitrogen, Karl-
sruhe, Germany) in the presence of 0.12 mM dATP, dGTP
and dTTP and 0.06 mM dCTP, in a total volume of 50 μL.
After 2 hours incubation at 37°C, the reaction was
stopped by adding 5 μL of 0.5 M EDTA.
2. Labelling during amplification
Labelling during PCR was performed directly, by incorpo-
ration of fluorescent nucleotides, or indirectly by incorpo-
ration of aminoallyl-modified nucleotides and
subsequent staining of the amplified products with amino
reactive fluorescent dyes. The LSplex PCR protocols using
Taq or Vent exo- DNA polymerases were modified as fol-
lows: 1) for direct labelling the amount of dTTP was
reduced to 0.15 mM and 0.05 mM of Alexa Fluor 546-14-
dUTP was added (ChromaTide Labelled Nucleotides,
Molecular Probes, Willow Creek, US). 2) for indirect
labelling the amount of dTTP was reduced to 0.13 mM
and 0.07 mM aminoallyl-dUTP was added (ARES DNA
labelling Kit, Invitrogen). Amino-modified amplified
DNA was spin purified with the QIAquick PCR Purifica-
tion Kit (Qiagen), eluted in 60 μL nuclease-free water (pH
8), analyzed by spectrophotometry, freeze-dried (Lyovac
GT2, Finn-Aqua, Huerth, Germany), resuspended in 5 μL
nuclease-free water and subsequently stained with Alexa-
fluor 555 or 647.
3. Labelling of genomic DNA
For some comparative experiments, bacterial or fungal
pure culture genomic DNAs have been fragmented by
sonification (Bandelin, Berlin, Germany) to an average
size of 1000 bp and then also been labelled by random
priming and Klenow Polymerase as described above (1.
Labelling after amplification).
Finally, labelled LSplex products and genomic DNA were
spin purified with the QIAquick PCR Purification Kit
(Qiagen) and eluted in 60 μL elution buffer (10 mM Tris/
HCl, pH 8.0). The labelling efficiency was evaluated by
calculating the approximate ratio of bases to dye mole-
cules. This ratio and the amount of recovered labelled
DNA was determined by measuring the absorbance of the
undiluted purified LS-Plex products at 260 nm and the
absorbance of the dye at its absorbance maximum using a
lambda40 UV-spectrophotometer (PerkinElmer) and
plastic disposable cuvettes for the range from 220 nm to
700 nm (UVette; Eppendorf, Hamburg, Germany).
Microarray hybridization and analysis
In order to provide a complete evaluation of the LSplex
protocol using genus-specific and high complexity primer
mixes, amplified products were hybridized to a prototype
microarray designed to identify pathogenic microorgan-
isms involved in sepsis.
All amplifications were performed at least twice for each
condition indicated. Each experiment described in the
present study represent co-hybridization of two different
DNA samples (LSplex amplified and genomic DNA for
comparison) labelled with Cy3, Alexa 546 or Alexa 555
and Cy5 or Alexa 647 respectively. After purification, DNA
samples labelled with distinguishable fluorophores were
pooled and 10 μg of Salmon Sperm DNA were added. The
whole yield of one amplification reaction was used for
one labeling and hybridization experiment. The mixture
was frozen in liquid nitrogen and freeze-dried (Lyovac
GT2, Finn-Aqua, Huerth, Germany) in the dark. Hybridi-
zation was automatically performed with a TECAN
hybridization station (HS400, TECAN, Salzburg, Austria).BMC Microbiology 2009, 9:1 http://www.biomedcentral.com/1471-2180/9/1
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The microarray slides were prewashed with 5 × SSC then
110 μL of pre-hybridization buffer (25% Formamide, 5 ×
SSC, 0.1% SDS, 10 mg/ml BSA) were added and incu-
bated for 30 minutes at 42°C with mild agitation. Lyophi-
lized labelled DNA was resuspended in 110 μL of
hybridization buffer (25% Formamide, 5 × SSC, 0.1%
SDS), denatured for 3 minutes at 90°C, and injected into
the hybridization chambers. Hybridization was per-
formed for 18 hours at 42°C. After hybridization the
arrays were automatically washed at 42°C in 1 × SSC/
0.1% SDS, three cycles of 30 sec wash time and 2 min soak
time, then in 0.1 × SSC/0.1% SDS, five cycles of 30 sec
wash time and 2 min soak time, in 0.1 × SSC, four cycles
of 30 sec wash time and 2 min soak time and finally dried
at 30°C with N2 (270 MPa) for 5 min.
Hybridized arrays were scanned with a GenePix Personal
Axon 4100A laser scanner (Axon Instruments, Union city,
CA). Laser light of wavelengths at 532 and 635 nm were
used to excite Cy3/Alexa546/Alexa555 dyes and Cy5/
Alexa647 dyes, respectively. Fluorescent images were ana-
lyzed by the GenePixPro software (v.6.0) and Acuity
(v.4.0) (Axon Instruments). The intensity of fluorescence
of each spot was measured and the mean of 4 replicate
spots per probe was calculated. Local background fluores-
cence was also measured and subtracted from the mean
fluorescence. Spots displaying fluorescence greater than
mean fluorescence of all spots on the array plus two times
standard deviation (SD) were considered as positive. The
hybridization was considered successful if spiked and
control spots produced positive signals. Presence of more
than 5 positive spots from same species was interpreted as
positivity of the sample for this pathogen species. The
fidelity limit of LSplex was defined as minimal amount of
DNA necessary to obtain the hybridization pattern with
>95% correspondence to one from the 2 μg genomic
DNA.
Results
We have recently established a prototype medium-density
gene-segment DNA microarray for the detection and
genetic profiling of pathogens causing bloodstream infec-
tions [2]. The limit of detection of such medium-density
gene-segment DNA microarrays was previously identified
and ranged between 10 and 100 ng of DNA [2]. This
microarray has been extended for the present study to rep-
resent specific gene fragments of more than 20 of the most
prominent causative agents of sepsis [15]. As expected the
sensitivity of detection was not influenced by the exten-
sion of the microarray. This was confirmed experimentally
by hybridizing decreasing amounts of bacterial genomic
DNA (Additional file 2). At the nanogram level a striking
reduction in the detection power was observed and the
number of detected genes was gradually reduced. In order
to improve the sensitivity of detection we focused on the
development of an amplification protocol by multiplex
PCR.
Large scale multiplex PCR with 800-primer pairs (LSplex)
The amplification of unidentified pathogen DNA requires
that all necessary primer pairs are present in the amplifi-
cation mix. We have initially addressed the question
whether it is possible to amplify genomic DNA of several
bacterial species by a PCR containing 800 primer pairs
(Additional file 1). However, the complexity of the primer
mix did not allow the amplification of any genomic DNA
at a final primer concentration of 0.2 μM (data not
shown). Nevertheless, reducing the primer concentration
in the amplification reaction to 0.02 μM permitted ampli-
fication from 100 ng of some DNA templates, although
the amplification of most DNA templates was very weak
(Fig 1A). It was not possible to further decrease the final
concentration of individual primers without a negative
effect on the amplification yield (not shown). Further-
more, DNA templates from Gram-negative bacteria could
not be amplified using Taq DNA polymerase at any
primer concentration (not shown). An optimized proto-
col using Vent exo- DNA polymerase permitted the ampli-
fication of these templates with 800-primer pairs at
different concentrations (Fig. 1B). LSplex produced pat-
terns corresponding to the expected size range of PCR
products, where each band represents the collection of
many amplicons of approximately the same size. Further-
more, absence of amplification was observed in reactions
without or with unrelated DNA (e.g. human genomic
DNA) indicating specific amplification of bacterial DNA
(data not shown). Best results were obtained with final
primer concentrations between 0.01 and 0.05 μM and
with a primer concentration of 0.02 μM we successfully
amplified an expanded panel of test species including
Gram-positive and Gram-negative bacteria as well as Can-
dida albicans DNA (Fig. 1C).
Adapting LSplex to microarray hybridization
To demonstrate specificity of LSplex the amplified DNA
was fluorescently labelled and hybridized with the patho-
gen-specific microarray.
In microarray analysis the labelling of genomic DNA by
random priming and the incorporation of nucleotides
tagged with fluorophores is accomplished using the Kle-
now fragment of the DNA polymerase. This method was
employed for LSplex amplified products obtained from
10 ng of S. aureus DNA template. The final amount of
labelled DNA was high (1.3 μg) and the incorporation of
fluorescent nucleotides was efficient (1 nucleotide each
61 bases) (Table 1). The hybridization of Klenow labelled
LSplex products reliably reproduced the probe profile
obtained with 2 μg of Klenow-labelled genomic DNA
(Fig. 2A and 2C). All specific probes that did not hybridizeBMC Microbiology 2009, 9:1 http://www.biomedcentral.com/1471-2180/9/1
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Large scale multiplex PCR with 800 primer pairs Figure 1
Large scale multiplex PCR with 800 primer pairs. Gel electrophoresis of PCR products obtained with high complexity 
800-primer pair mix (Additional file 1) with a final concentration of 0.02 μM for each individual primer pair and using Taq 
polymerase (standard LSplex) (A) or using vent exo-polymerase (B and C). Efficiency of LSplex using primer mix with different 
individual primer concentrations (B). Optimized LSplex amplification of various DNA templates from Gram-negative, Gram-
positive bacteria and Candida albicans (C). 100 ng genomic DNA from each indicated species served as template.BMC Microbiology 2009, 9:1 http://www.biomedcentral.com/1471-2180/9/1
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with genomic DNA of S. aureus ATCC 29213 were still
negative after amplification. For instance those identify-
ing the serotype 8 (cap8 genes), exfoliative toxins A (eta)
and B (etb), enterotoxin B (seb), C (sec), H (seh) and L
(sel) or toxic shock syndrome toxin-1(tst) (Fig. 2A and
2C).
Impact of labeling method on the detection efficiency
In order to reduce the number of steps in the labeling pro-
cedure and to shorten the labeling time we attempted to
label DNA by incorporation of modified nucleotides con-
comitantly to the amplification procedure. Additionally,
the impact of different labeling methods on general
LSplex specificity and sensitivity upon microarray hybrid-
ization were evaluated.
The possibility of directly incorporating fluorescent nucle-
otides during LSplex amplification was examined. Chro-
matide Alexa Fluor 546-47-dUTPs were used for
amplification but resulted in a rather weak incorporation
ratio (one fluorescent nucleotide each 139 bases) (Table
1). The corresponding hybridization profile of S. aureus
specific probes was barely more informative than the one
obtained with 10 ng of non-amplified genomic DNA (Fig.
2D and 2B).
The indirect labeling of LSplex products by incorporating
aminoallyl-modified nucleotides during amplification,
with subsequent staining by amino reactive fluorescent
dyes, was a potential alternative to Klenow labeling with
one tagged nucleotide per 64 bases. Some probes dis-
played reduced fluorescence when compared to the fluo-
rescence levels obtained with LSplex amplification plus
Klenow labeling (Fig. 2E). For example the 2nd catalase
probe (cata), the 4th coagulase (coa), bsaG, all capsular
polysaccharide type 5 related genes (cap5), the gamma
hemolysin (hglA), and the enterotoxines G (seg) and T15
(set15) showed weaker signals but were nonetheless iden-
tified as positive. Notably, LSplex amplification combined
with indirect labeling granted a saving of one hour time
compared to LSplex amplification with subsequent Kle-
now-labeling (Table 1).
Limits of sensitivity of LSplex
Next we wished to determine the minimum amount of
target DNA efficiently supporting the optimized LSplex
amplification protocol. Agarose gel electrophoresis was
unable to detect the LSplex amplification products from
templates containing less than 10 ng of DNA (105–106
genomic equivalents) from several bacterial species (not
shown).
However, after fluorescent labeling of the amplification
products followed by microarray hybridization strong sig-
nals were readily detected. In fact, LSplex amplification
(with 800 primer pairs) of 10 ng and also of 1 ng of DNA
template resulted in a hybridization pattern mostly iden-
tical to the one obtained with 2 μg of genomic DNA, while
10 ng of the same genomic DNA were below the limit of
sensitivity of the microarray for pathogen detection (Fig.
3). The hybridization pattern obtained with 100 ng
genomic DNA showed 22 mismatches compared to 2 μg.
In contrast, LSplex on 1 ng template displayed a hybridi-
zation profile comparable to the one obtained with 2 μg
of non amplified DNA, although the amplification of cer-
tain probes was diminished. For instance, lipase (lip)
delta-aminolevulinic acid dehydratase (hemB) and Pan-
tone-Valentine leukocidin F subunit (lukF) were poorly
amplified and fell below detection threshold. Most of the
LSplex products amplified from 0.1 ng or 0.01 ng (not
shown) template were below the limit of detection of the
microarray analysis, making species identification impos-
Table 1: Comparison of LSplex labelling methods
Labelling Method Description Final amount of 
DNA1 (μg)
Base/Dye ratio2 Labelled nucleotides Processing time
Random Priming labelling after 
amplification with Klenow 
DNA polymerase
1.3 61 dCTP-Cy3 1.5 h LSplex, 15 min 
purification; 2 h labelling, 
15 min purification
Chromatide direct incorporation of 
fluorescent nucleotides 
during Lsplex
0.7 139 Alexa Fluor 546-14-
dUTP(1:3)3
1.5 h LSplex, 15 min 
purification
ARES incorporation of amino-
modified nucleotides 
during Lsplex staining 
with Amino-reactive dye
1.1 64 aminoallyl-dUTP (1:2)4 
stained after PCR with 
Alexa Fluor 555
1.5 h Lsplex, 15 min 
purification; 1 h post 
staining, 15 min 
purification
1. Amplified DNA estimated after the last purification step. The starting material for all protocols was 10 ng genomic S. aureus DNA (ATCC 29213)
2. BDR calculated following the formula: base:dye = (Abase × dye)/(Adye × base); Abase = A260 - (Adye × CF260) dye is the extinction coefficient for the 
fluorescent dye (Cy3: 150000 cm-1M-1; Alexa555: 150000 cm-1M-1; Alexa 546: 104000 cm-1M-1) base here is the average extinction coefficient for a 
base in double strand DNA (6600 cm-1M-1) CF: Correction Factor Cy3: 0.08; Alexa 555: 0.04; Alexa 546: 0.21
3. Ratio recommended by the manufacturer for PCR labelling
4. The manufacturer does not provide a protocol for PCR labellingBMC Microbiology 2009, 9:1 http://www.biomedcentral.com/1471-2180/9/1
Page 7 of 14
(page number not for citation purposes)
sible. Thus application of LSplex increases the microarray
detection of target templates by a factor of 102 to 103 with
>95% fidelity.
Specificity of LSplex on several DNA templates
In the next step we evaluated if the PCR amplification
employing 800 primer pairs results in the generation of
nonspecific amplification products cross-hybridizing with
non-target species. The specificity of the LSplex protocol
was evaluated by measuring the fluorescent signals in the
whole array after hybridization with LSplex products (800
primer pairs) obtained from 10 ng of DNA (approx 105
genomic equivalents) of 9 different species of pathogens
(Staphylococcus aureus ATCC 29213, Escherichia coli ATCC
Microarray detection of LSplex amplification products labelled by different techniques Figure 2
Microarray detection of LSplex amplification products labelled by different techniques: Hybridization pattern of 
specific capture probes obtained upon hybridization of 2 μg (A) and 10 ng of S. aureus DNA (B) served as standard for compar-
ison of the profiling fidelity and sensitivity of three labelling protocols for LSplex. LSplex amplification of 10 ng S. aureus DNA 
with subsequent labelling by random priming (C). Direct incorporation of Chromatide Alexa Fluor 546-47-dUTPs during 
LSplex amplification (D). Indirect labelling by incorporating amino-modified nucleotides during LSplex and subsequent coupling 
with amino reactive dyes (E).BMC Microbiology 2009, 9:1 http://www.biomedcentral.com/1471-2180/9/1
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25922, Streptococcus pneumoniae CIP 106577, Enterococcus
faecalis ATCC 29212, Proteus mirabilis DSM 788, Staphylo-
coccus epidermidis ATCC 12228, Klebsiella pneumoniae DSM
681, Candida albicans ATCC 10231 and Pseudomonas aeru-
ginosa ATCC 27853). Results are summarized in figure 4.
As shown above, LSplex of S. aureus DNA allowed unam-
biguous species identification and discrimination from
coagulase negative Staphylococci. Hybridization profiles
of LSplex products corresponded very well with the
expected hybridization profiles from genomic DNA (not
shown). Amplified S. epidermidis DNA hybridized specifi-
cally to S. epidermidis capture probes and showed no cross-
hybridizations with S. aureus capture probes as well as
with capture probes of other coagulase negative staphylo-
cocci. Similar results were obtained with LSplex products
of S. pneumonia DNA leading to clear-cut species identifi-
cation and differentiation from all other Streptococci spe-
cies. LSplexed E. faecalis DNA displayed high specificity to
probes of E. faecalis, showing no cross hybridization with
the closely related species E. faecium. The same was
observed in hybridization experiments with P. mirabilis
DNA. Notably, LSplex products of 10 ng C. albicans DNA
produced highly specific signals, with 4 to 5-times greater
fluorescence intensity than those produced by 2 μg of
genomic DNA.
Application of LSplex for microbiological diagnostics
In order to demonstrate benefits of LSplex for the micro-
array-based detection of pathogens in clinical specimens
we analysed cotton swabs taken from patients with super-
ficial wounds. Such swabs represent one of the most fre-
quent materials processed by microbiological diagnostics.
Swabs from superficial wounds contain one or more path-
ogens, normal skin flora and few human cells. The
number of bacteria on swabs is usually low, so that time
consuming amplification via subculture on microbiologi-
cal media is required. DNA was isolated from three swabs
taken from the same patient. DNA preparations were
pooled and divided into two samples of approximately 20
ng each. One sample was subjected to LSplex (800 primer
pairs). Other labeled directly prior to hybridization with
the microarray. A typical hybridization pattern is depicted
in figure 5. The directly labeled DNA hybridized only with
16S RNA probes (positive controls) indicating the pres-
ence of bacterial DNA in the sample (Fig. 5). However, the
hybridization of directly labeled DNA did not allow iden-
tification of the pathogen species. This was not due to
inefficient labeling of the DNA as demonstrated by strong
hybridization of the control DNA spiked into the labeling
reaction. In contrast, LSplex amplified swab DNA hybrid-
ized with probes of Enterococcus faecium and Staphylococcus
epidermidis (Fig. 5). The presence of these bacterial species
was confirmed by routine microbiological culture fol-
lowed by biochemical characterization. It should be noted
that LSplex of the DNA from swab resulted in hybridiza-
Enhancement of sensitivity of pathogen DNA detection by  microarray by LSplex amplification Figure 3
Enhancement of sensitivity of pathogen DNA detec-
tion by microarray by LSplex amplification. Hybridiza-
tion profile of non-amplified genomic S. aureus DNA (2 μg, 
100 ng, 10 ng and 1 ng) and indirectly labelled LSplex amplifi-
cation product of the same DNA starting from 10 ng, 1 ng 
and 0.1 ng template (columns). Each row represents individ-
ual S. aureus-specific capture probes as well as positive (16S-
derived probes) and negative controls. Fluorescent signals 
were quantified and classified as positive (black boxes) 
hybridization or absence of hybridization (white boxes).BMC Microbiology 2009, 9:1 http://www.biomedcentral.com/1471-2180/9/1
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Specific detection of microbial DNA by LSplex amplification Figure 4
Specific detection of microbial DNA by LSplex amplification. Hybridization profiles generated by analysis of LSplex 
amplified products shown as columns (S. aureus, E. coli, S. pneumonia, E. faecalis, P. mirabilis, S. epidermidis, K. pneumoniae, C. albi-
cans and P. aeruginosa). Each row represents an individual capture probe of the microarray, grouped by species or genus spe-
cific regions (see Additional file 2) as indicated in the left column. The boxes represent the positive hybridization signal of 
bacterial DNA (in colour) or absence of hybridisation (in white) with individual capture probes.BMC Microbiology 2009, 9:1 http://www.biomedcentral.com/1471-2180/9/1
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tion of a few probes from other bacteria (one of from K.
pneumoniae, two from P. aeruginosa, three from S. aureus
and one from S. pneumoniae) which were not identified by
microbiological culture. These, however were only single-
tons in the redundant set of dozens of species-specific
probes, allowing the correct identification of pathogens
present in the specimen. In summary the results of LSplex
amplification of DNA from cotton swabs followed by
microarray were in concordance with the standard micro-
biological techniques, whilst direct microarray identifica-
tion of the pathogens was not successful.
Discussion and conclusion
The applicability of fluorescence-based DNA microarrays
for the direct detection and characterization of pathogens
depends on amplification of the target DNA [21]. To com-
pensate for the low sensitivity of such a multi-capture
probe detection system, microarray analysis can be pre-
ceded of pathogen isolation and clonal expansion as a
source for abundant DNA. A pre-amplification of the tar-
get DNA using a single-step Large Scale multiplex PCR
(LSplex) could avoid such a time-consuming procedure.
Although it is generally accepted that Multiplex PCR is
potentially an ideal co-adjuvant for DNA microarrays in
pathogen detection [21] there is, nevertheless, a limitation
in the number of distinct PCR products that can be gener-
ated. Up to date, multiplex PCR was only combined with
low-density microarray formats [22] and required either
several parallel multiplex PCR reactions [5,17,23] or sub-
sequent PCR steps [6,24].
The complex nature of the interference between multiple
primer pairs and targets [25,26,21] has limited conven-
tional multiplex PCR in solution phase to a dozen of
primer pairs [27-29]. Antagonizing the typical hindrances
of highly multiplexed PCR requires innovative technical
platforms as for instance performing on-chip amplifica-
tion with primers attached to a solid support [26].
Another alternative approach applied to solution-phase
highly multiplex PCR has been the replacement of target-
specific primers with universal ones. However, this proc-
ess involves multiple steps starting with enzymatic diges-
tion of the template DNA, ligation to adapters, primer
extension and finally two subsequent PCR reactions
[30,31]. Such multi-step approaches are time consuming
and prone to contamination [25] and therefore have not
been recommended for bacteriological routine diagnos-
tics.
The coupling of a pre-processing multiplex PCR to a
medium-density microarray format, displaying hundreds
of probes for identification and virulence profile typing of
several pathogenic species, requires an unbiased multi-
target amplification corresponding to several dozens of
specific capture probes characterizing a certain pathogen.
Since the presence and concentration of the particular
pathogen in a microbiological laboratory is unknown, the
multiplex reaction should include as many primer pairs as
capture probes are present on the microarray. Moreover,
the reaction has to cope with femtograms of pathogen
template DNA whose GC-content can range between 30
and 70% and which is mixed with nanograms of human
DNA.
We have shown high fidelity amplification of specific
DNA targets using pools of species-specific mixes of up to
800 primer pairs, which improves the sensitivity of the
microarray detection of pathogens by a factor of 2 to 3-
logs.
By using S. aureus DNA (strain ATCC 29213) as template
for amplification, we demonstrated that LSplex tolerates
the increase in primer mix complexity until at least 800
primer pairs, without significant reduction in the profiling
fidelity. LSplex products amplified from 10 and even 1 ng
of template generated fluorescent signals as strong as
those produced by micrograms of genomic DNA. Never-
theless, the comparison between LSplex hybridization
profiles and the ones obtained with 2 μg of S. aureus
showed that some probes were poorly amplified with the
high complexity primer mixes. These probes produced a
strong fluorescent signal when hybridized with genomic
DNA but upon the LSplex protocol they were not consid-
ered as positive since their fluorescence difference was less
then 2 times SD to the mean fluorescence intensity of the
whole microarray. This problem of under-amplification
of some targets might be circumvented by a specific
increase in the concentration of primer pairs amplifying
these specific targets [32]. Such a balancing strategy for
individual primer pairs could be applied on the whole set
of primers, following a broad comparison between
hybridization profiles generated by genomic DNA of
many reference strains of all species of interest and the
LSplex amplified products. In this way, the amount of all
primer pairs responsible for low amplification yield can
be adjusted. Cut-off values supporting the decision
between positive or negative signals are determined
empirically and should be specifically adapted to different
experimental setups. Although several calculation meth-
ods are described in the literature, they basically represent
subjective evaluation of the signal to noise ratio. Some
authors consider a signal positive when it is only two or
three times higher than the assay background [33,16],
while others take only signals ten times higher [23].
The fact that the LSplex protocol could allow concomitant
amplification and labelling represents a valuable feature
for future application in diagnostics since it should reduce
the total time required for providing the identification of
the pathogen. The optimized LSplex protocol using VentBMC Microbiology 2009, 9:1 http://www.biomedcentral.com/1471-2180/9/1
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Application of LSplex for detection of bacterial mixtures from clinical specimens Figure 5
Application of LSplex for detection of bacterial mixtures from clinical specimens. Hybridization profiles generated 
by DNA isolated from cotton swab of superficial wound. DNA was labeled prior to hybridization without amplification (green) 
or after LSplex (red). Each row represents an individual capture probe of the microarray, grouped by species or genus specific 
regions (see Additional file 2) as indicated in the left column. The boxes represent the positive hybridization signal of bacterial 
DNA (in color) or absence of hybridization (in white) with individual capture probes. The presence of E. faecium and S. epider-
midis on swab was verified by routine microbiological diagnostic procedures.BMC Microbiology 2009, 9:1 http://www.biomedcentral.com/1471-2180/9/1
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exo- performed reliable amplification and efficient incor-
poration of amino-allyl modified nucleotides, allowing
indirect labelling of PCR products. However, direct incor-
poration of fluorescent nucleotides during the multiplex
PCR under the same amplification conditions led to weak
label incorporation making the separate labelling step
necessary to achieve a good profiling fidelity. Alterna-
tively, the use of labelled primers can be employed for
obtaining fluorescent multiplex PCR products [34].
LSplex successfully amplified less than 10 nanograms of
DNA from several different pathogens (Gram-positive,
Gram-negative and fungi) generating signals in general
stronger and more specific than the ones generated with
2–5 micrograms of DNA. LSplex improved the specificity
of the hybridization assay and enriched the sample for the
target sequences present in the template. Interestingly,
Candida albicans produced non-detectable signals when 2
μg of genomic DNA are used for hybridization. After
amplification of 10 ng of C. albicans DNA by LSplex pro-
tocol resulted in the clear hybridization pattern (Fig. 4).
We would like to emphasize that a reduction in the limit
of sensitivity of the LSplex protocol to picograms or to
femtograms would be desirable in order to detected path-
ogens directly from every clinical, food or environmental
samples.
In the last two years the publication of several reports
referring to rapid identification of bacterial species by
multiplex PCR coupled to microarrays detection
[5,35,6,17,16,36-38,17,3,37,3,4,23,7] demonstrated the
usefulness of this approach and the growing interest in
implementing it in routine diagnostics. It also underlines
the necessity of finding robust protocols for amplifying
the target DNA before microarray analysis.
Whole genome amplification (WGA) is a powerful tech-
nique for the amplification of total genomic DNA (e.g. for
comparative hybridization [39]). However, the random
priming employed in WGA will amplify every DNA in the
sample. Therefore, the application of WGA is difficult if
the DNA of interest is contaminated by unwanted DNA.
This is the case in clinical microbiology settings where
DNA extracted directly from patient sample contains a sig-
nificant amount of human DNA. LSplex would amplify
selectively the underrepresented bacterial DNA. The large
set of primer pairs is potentially able to amplify as many
gene segments as probes are immobilized on the proto-
type microarray but in practice, it is supposed to only
amplify the gene-segments specific to the pathogens
present in the analyte.
In parallel, real-time PCR-based assays for identification
of pathogens were proposed since the sensitivity is ade-
quate for direct detection and quantification [10-12,40-
43]. However, the information level obtained by this
approach is incomparably lower than the one provided by
medium or high density microarray analyses. Real-time
PCR has a reduced potential for multiplexing because the
current availability of only four to five channels for the
simultaneous non-overlapping detection of different
fluorophores [21]. For this reason, real-time PCR is in gen-
eral confined to a mere species identification based on
single sequence polymorphism [10,43] or to confirm the
presence of a suspected pathogen by using a reduced
number of specific primer pairs [44,45] eventually com-
pleted by the detection of a few genes related to antibiotic
resistance [46,45]. In contrast, microarrays offer the possi-
bility to profile pathogens by providing information at
the strain level [36], by detecting virulence factors and
genes determining the antibiotic resistance [16]. The
LSplex amplification protocol is a promising co-adjuvant
for pathogen profiling by microarray analysis since it
increases sensitivity and the specificity of detection. It also
presents the flexibility of using hundreds of primer pairs,
whose sequences are exchangeable in function of the
pathogens targeted in the microarray. The single-step
LSplex protocol, allowing labelling during amplification,
could represent one piece of the methodological mosaic
in a future time-saving bacteriological diagnostic
approach.
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